AMPK activation is involved in hypoglycemic and hypolipidemic activities of mogroside-rich extract from: Siraitia grosvenorii (Swingle) fruits on high-fat diet/streptozotocin-induced diabetic mice

Food and Function

Volumn 10, Issue 1, 2019, Pages 151-162

  Liu, Hesheng ^a,b   Qi, Xiangyang ^a   Yu, Keke ^a   Lu, Anjie ^a   Lin, Kaifeng ^a   Zhu, Jiajing ^a   Zhang, Min ^a,c   Sun, Zhida ^b  

^a ZHEJIANG WANLI UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c BEIJING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CHEMICAL ACTIVATION; GENES; GLUCOSE; MAMMALS; PROTEINS;

AMP-ACTIVATED PROTEIN KINASE; DOSE-DEPENDENT MANNER; HOMEOSTASIS MODEL ASSESSMENTS; HYPOLIPIDEMIC EFFECT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ACCUMULATIONS; POTENTIAL EFFECTS;

INSULIN;

AMP-ACTIVATED PROTEIN KINASE KINASE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; GLUCOSIDE; PLANT EXTRACT; PROTEIN KINASE; STREPTOZOCIN;

ANIMAL; C57BL MOUSE; CHEMISTRY; CUCURBITACEAE; DRUG EFFECT; ENZYMOLOGY; FRUIT; GENETICS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID DIET; LIVER; MALE; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; BLOOD GLUCOSE; CUCURBITACEAE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FRUIT; GLUCONEOGENESIS; GLUCOSIDES; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; PROTEIN KINASES; STREPTOZOCIN;

EID: 85060218573     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c8fo01486h     Document Type: Article

References (54)

1. V. Fonseca Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus Curr. Med. Res. Opin. 2003 19 635 631
2. S. E. Inzucchi Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review J. Am. Med. Assoc. 2002 287 360 372
3. M. R. Taskinen J. Borén New insights into the pathophysiology of dyslipidemia in type 2 diabetes Atherosclerosis 2015 239 483 495
4. D. E. Moller New drug targets for type 2 diabetes and the metabolic syndrome Nature 2002 414 821 827
5. B. Satirapoj S. G. Adler Comprehensive approach to diabetic nephropathy Kidney Res. Clin. Pract. 2014 33 121 131
6. J. Naveen V. Baskaran Antidiabetic plant-derived nutraceuticals: a critical review Eur. J. Nutr. 2018 57 1275 1299
7. Y. S. Oh H. S. Jun Role of Bioactive Food Components in Diabetes Prevention: Effects on Beta-Cell Function and Preservation Nutr. Metab. Insights 2014 7 51 59
8. B. B. Kahn T. Alquier D. Carling D. G. Hardie AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism Cell Metab. 2005 1 15 25
9. D. G. Hardie AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function Genes Dev. 2011 25 1895 1908
10. K. A. Coughlan R. J. Valentine N. B. Ruderman A. K. Saha AMPK activation: a therapeutic target for type 2 diabetes? Diabetes, Metab. Syndr. Obes. 2014 7 241 253
11. L. Tao J. Yang F. Cao H. Xie M. Zhang Y. Gong C. Zhang Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways J. Pharmacol. Exp. Ther. 2017 361 268 279
12. J. S. Jin J. H. Lee Phytochemical and pharmacological aspects of Siraitia grosvenorii, luo han kuo Orient. Pharm. Exp. Med. 2012 12 233 239
13. T. Takemoto S. Arihara T. Nakajima M. Okuhira Studies on the constituents of fructus Momordicae. I. On the sweet principle Yakugaku Zasshi 1983 103 1151 1154
14. F. Xu D. P. Li Z. C. Huang F. L. Lu L. Wang Y. L. Huang R. F. Wang G. X. Liu M. Y. Shang S. Q. Cai Exploring in vitro, in vivo metabolism of mogroside V and distribution of its metabolites in rats by HPLC-ESI-IT-TOF-MSn J. Pharm. Biomed. Anal. 2015 115 418 430
15. R. S. Pawar A. J. Krynitsky J. I. Rader Sweeteners from plants - with emphasis on Stevia rebaudiana (Bertoni) and Siraitia grosvenorii (Swingle) Anal. Bioanal. Chem. 2013 405 4397 4407
16. M. H. Pan J. R. Yang M. L. Tsai S. Sang C. T. Ho Anti-inflammatory effect of Momordica grosvenori Swingle extract through suppressed LPS-induced upregulation of iNOS and COX-2 in murine macrophages J. Funct. Foods 2009 1 145 152
17. J. S. Jin J. H. Lee Phytochemical and pharmacological aspects of Siraitia grosvenorii, luo han kuo Orient. Pharm. Exp. Med. 2012 12 233 239
18. X. Qi W. Chen L. Liu P. Yao B. Xie Effect of a Siraitia grosvenori extract containing mogrosides on the cellular immune system of type 1 diabetes mellitus mice Mol. Nutr. Food Res. 2006 50 732 738
19. X. B. Chen J. J. Zhuang J. H. Liu M. Lei L. Ma J. Chen X. Shen L. H. Hu Potential AMPK activators of cucurbitane triterpenoids from Siraitia grosvenorii Swingle Bioorg. Med. Chem. 2011 19 5776 5781
20. Z. Luo F. Qiu K. Zhang X. Qin Y. Guo H. Shi L. Zhang Z. Zhang X. Ma In vitr o, AMPK activating effect and in vivo pharmacokinetics of mogroside V, a cucurbitane-type triterpenoid from Siraitia grosvenorii fruits RSC Adv. 2016 6 7034 7041
21. N. Harada M. Ishihara H. Horiuchi Y. Ito H. Tabata Y. A. Suzuki Y. Nakano R. Yamaji H. Inui Mogrol Derived from Siraitia grosvenorii Mogrosides Suppresses 3T3-L1 Adipocyte Differentiation by Reducing cAMP-Response Element-Binding Protein Phosphorylation and Increasing AMP-Activated Protein Kinase Phosphorylation PLoS One 2016 11 e0162252
22. H. Liu C. Wang X. Qi J. Zou Z. Sun Antiglycation and antioxidant activities of mogroside extract from Siraitia grosvenorii (Swingle) fruits J. Food Sci. Technol. 2018 55 1880 1888
23. L. Yu W. Cai Y. Zhang L. Feng C. Huang Red bayberry extract prevents high-fat diet-induced metabolic disorders in C57BL/6 mice J. Funct. Foods 2015 14 278 288
24. J. Nie Y. Chang Y. Li Y. Zhou J. Qin Z. Sun H. Li Caffeic Acid Phenethyl Ester (Propolis Extract) Ameliorates Insulin Resistance by Inhibiting JNK and NF- κ B Inflammatory Pathways in Diabetic Mice and HepG2 Cell Models J. Agric. Food Chem. 2017 65 9041 9053
25. Y. Gao M. Zhang T. Wu M. Xu H. Cai Z. Zhang Effects of D-Pinitol on Insulin Resistance through the PI3 K/Akt Signaling Pathway in Type 2 Diabetes Mellitus Rats J. Agric. Food Chem. 2015 63 6019 6026
26. J. Ye G. Coulouris I. Zaretskaya I. Cutcutache S. Rozen T. L. Madden Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction BMC Bioinf. 2012 13 134
27. K. H. Kim S. Choi Y. Zhou E. Y. Kim J. M. Lee P. K. Saha S. Anakk D. D. Moore Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice Hepatology 2017 66 498 509
28. O. Akinrotimi R. Riessen P. VanDuyne J. E. Park Y. K. Lee L. J. Wong A. M. Zavacki K. Schoonjans S. Anakk Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice Hepatology 2017 66 1854 1865
29. P. J. Klover R. A. Mooney Hepatocytes: critical for glucose homeostasis Int. J. Biochem. Cell Biol. 2004 36 753 758
30. V. T. Samuel G. I. Shulman Mechanisms for Insulin Resistance: Common Threads and Missing Links Cell 2012 148 852 871
31. G. Jayanthy S. Subramanian RA abrogates hepatic gluconeogenesis and insulin resistance by enhancing IRS-1 and AMPK signalling in experimental type 2 diabetes RSC Adv. 2015 5 44053 44067
32. Y. Zhang F. Y. Lee G. Barrera H. Lee C. Vales F. J. Gonzalez T. M. Willson P. A. Edwards Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice Proc. Natl. Acad. Sci. U. S. A. 2006 103 1006 1011
33. X. Y. Qi W. J. Chen L. Q. Zhang B. J. Xie Mogrosides extract from Siraitia grosvenor i, scavenges free radicals in vitro and lowers oxidative stress, serum glucose, and lipid levels in alloxan-induced diabetic mice Nutr. Res. 2008 28 278 284
34. Z. Chen C. Wang Y. Pan X. Gao H. Chen Hypoglycemic and hypolipidemic effects of anthocyanins extract from black soybean seed coat in high fat diet and streptozotocin-induced diabetic mice Food Funct. 2018 9 426 439
35. I. Cordero-Herrera M. Á. Martín L. Goya S. Ramos Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells Food Chem. Toxicol. 2014 64 10 19
36. Q. F. Collins H. Y. Liu J. Pi Z. Liu M. J. Quon W. Cao Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5′-AMP-activated Protein Kinase J. Biol. Chem. 2007 282 30143 30149
37. J. M. Lee W. Y. Seo K. H. Song D. Chanda Y. D. Kim D. K. Kim M. W. Lee D. Ryu Y. H. Kim J. R. Noh C. H. Lee J. Y. L. Chiang S. H. Koo H. S. Choi AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB/CRTC2 complex by orphan nuclear receptor SHP J. Biol. Chem. 2010 285 32182 32191
38. S. J. Jiang H. Dong J. B. Li L. J. Xu X. Zou K. F. Wang F. E. Lu P. Yi Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats World J. Gastroenterol. 2015 21 7777 7785
39. Z. Ren Z. Xie D. Cao M. Gong L. Yang Z. Zhou Y. Ou C-Phycocyanin inhibits hepatic gluconeogenesis and increases glycogen synthesis via activating Akt and AMPK in insulin resistance hepatocytes Food Funct. 2018 9 2829 2839
40. J. M. Chehade M. Gladysz A. D. Mooradian Dyslipidemia in Type 2 Diabetes: Prevalence, Pathophysiology, and Management Drugs 2013 73 327 339
41. J. A. Farmer Diabetic dyslipidemia and atherosclerosis: Evidence from clinical trials Curr. Diabetes Rep. 2008 8 71 77
42. H. J. Warraich J. S. Rana Dyslipidemia in diabetes mellitus and cardiovascular disease Cardiovasc. Endocrinol. Metab. 2017 6 27 32
43. I. Chopra H. F. Li H. Wang K. A. Webster Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle Diabetologia 2012 55 783 794
44. A. Tzatsos K. V. Kandror Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation Mol. Cell. Biol. 2006 26 63 76
45. T. Zheng X. Yang D. Wu S. Xing F. Bian W. Li J. Chi X. Bai G. Wu X. Chen Y. Zhang S. Jin Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3 K/Akt/GSK3β pathway Br. J. Pharmacol. 2015 172 3284 3301
46. Y. H. Kuo C. H. Lin C. C. Shih Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice J. Agric. Food Chem. 2015 63 10140 10151
47. J. Yang L. Craddock S. Hong Z. M. Liu AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells J. Cell. Biochem. 2009 106 414 426
48. Y. Li S. Xu M. M. Mihaylova B. Zheng X. Hou B. Jiang O. Park Z. Luo E. Lefai J. Y. J. Shyy B. Gao M. Wierzbicki T. J. Verbeuren R. J. Shaw R. A. Cohen M. Zang AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice Cell Metab. 2011 13 376 388
49. J. D. McGarry N. F. Brown The Mitochondrial Carnitine Palmitoyltransferase System - From Concept to Molecular Analysis Eur. J. Biochem. 1997 244 1 14
50. B. Viollet L. Lantier J. Devin-Leclerc S. Hebrard C. Amouyal R. Mounier M. Foretz F. Andreelli Targeting the AMPK pathway for the treatment of Type 2 diabetes Front. Biosci. 2009 14 3380 3400
51. P. Ferre The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity Diabetes 2004 53 43 50
52. S. Mandard M. Müller S. Kersten Peroxisome proliferator-activated receptor α target genes Cell. Mol. Life Sci. 2004 61 393 416
53. R. Kimura N. Takahashi K. Murota Y. Yamada S. Niiya N. Kanzaki Y. Murakami T. Moriyama T. Goto T. Kawada Activation of peroxisome proliferator-activated receptor-α (PPARα) suppresses postprandial lipidemia through fatty acid oxidation in enterocytes Biochem. Biophys. Res. Commun. 2011 410 1 6
54. M. Pawlak P. Lefebvre B. Staels Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease J. Hepatol. 2015 62 720 733